We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The war on high pharmaceutical prices continues, with PBM Express Scripts taking aim at what it calls an excessive price jump for Valeant Pharmaceuticals’ diabetes drug Glumetza. Read More
Two Alabama compounders face federal charges for selling tainted drugs that contributed to the deaths of nine people, according to federal prosecutors. Read More
Sharp price spikes for some orphan generics may be getting all of the attention today, but they have little real impact on overall prescription drug prices. Read More
After serving as Gilead Sciences’ CEO for 20 years, John C. Martin announced Friday that he is stepping down and will assume the role of executive chairman of the company. Read More
The EMA’s Committee for Medicinal Products for Human Use has recommended six new medicines for marketing authorization, including three innovators and three generics. Read More